Closes after the market
$Tilray Brands(TLRY.US$ 4th Quarter December 2019 loss of $0.62 per share on revenue of $46.9 million. The consensus estimate was a loss of $0.34 per share on revenue of $55.4 million.
$FibroGen(FGEN.US$ 4th Quarter December 2019 loss of $1.12 per share of revenue of $8.0 million. The consensus estimate was a loss of $0.62 per share on revenue of $30.7 million. FibroGen Inc is a research-based biopharmaceuticals company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
$Appfolio(APPF.US$4th Quarter December 2019 earnings of $0.12 per share on revenue of $67.4 million. The consensus estimate was $0.03 per share on revenue of $66.6 million. The company said it earned 2020 revenue of $312.0 million to $320.0 million. The current consensus estimate is revenue of $323.8 million for the year ending December 31, 2020.
$FibroGen(FGEN.US$ 4th Quarter December 2019 loss of $1.12 per share of revenue of $8.0 million. The consensus estimate was a loss of $0.62 per share on revenue of $30.7 million. FibroGen Inc is a research-based biopharmaceuticals company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
$Appfolio(APPF.US$4th Quarter December 2019 earnings of $0.12 per share on revenue of $67.4 million. The consensus estimate was $0.03 per share on revenue of $66.6 million. The company said it earned 2020 revenue of $312.0 million to $320.0 million. The current consensus estimate is revenue of $323.8 million for the year ending December 31, 2020.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment